Rein Therapeutics
RNTX
#10146
Rank
NZ$0.11 B
Marketcap
NZ$1.39
Share price
0.43%
Change (1 day)
-30.97%
Change (1 year)

Earnings for Rein Therapeutics (RNTX)

Earnings in 2026 (TTM): -NZ$36.68 Million

According to Rein Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$38.16 Million, an increase over its 2024 earnings that were of -NZ$48.91 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rein Therapeutics from 2016 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$36.68 Million-3.87%
2025 -NZ$38.16 Million-21.99%
2024 -NZ$48.91 Million83.16%
2023 -NZ$26.7 Million-44.49%
2022 -NZ$48.1 Million3.92%
2021 -NZ$46.29 Million29.81%
2020 -NZ$35.66 Million-31.58%
2019 -NZ$52.12 Million-6.1%
2018 -NZ$55.5 Million38.66%
2017 -NZ$40.03 Million26.63%
2016 -NZ$31.61 Million